What is the recommended treatment for alcohol withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Alcohol Withdrawal Syndrome

Benzodiazepines are the gold standard first-line treatment for alcohol withdrawal syndrome, with long-acting benzodiazepines like diazepam and chlordiazepoxide being preferred for most patients. 1, 2, 3

First-Line Pharmacological Treatment

  • Long-acting benzodiazepines (diazepam and chlordiazepoxide) are recommended for prevention of seizures and management of alcohol withdrawal syndrome through GABA activation 1, 2
  • Diazepam is administered at 5-10 mg every 6-8 hours orally, intravenously, or intramuscularly for most patients 2
  • For acute alcohol withdrawal, diazepam dosing is 10 mg, 3-4 times during the first 24 hours, reducing to 5 mg, 3-4 times daily as needed 4
  • Chlordiazepoxide is an alternative option at doses of 25-100 mg every 4-6 hours orally 1, 3
  • Diazepam has the shortest time to peak effect, facilitating rapid symptom control and accurate titration, while its long half-life provides a smoother withdrawal with lower risk of breakthrough symptoms 5

Special Population Considerations

  • Short and intermediate-acting benzodiazepines (lorazepam, oxazepam) are safer for high-risk patients, including those with:
    • Advanced age
    • Hepatic dysfunction
    • Respiratory failure
    • Obesity
    • Recent head trauma 1, 3
  • Lorazepam is typically administered at 1-4 mg every 4-8 hours (6-12 mg/day) and doesn't rely on hepatic oxidation, making it safer for patients with liver impairment 2, 3
  • Intramuscular administration of diazepam should be avoided due to slow absorption; lorazepam or midazolam should be used instead when rapid control is needed via this route 5

Adjunctive Treatments

  • Thiamine (100-300 mg/day) must be administered to all alcohol withdrawal patients to prevent Wernicke encephalopathy 1, 2
  • Thiamine should always be given before any glucose-containing IV fluids to prevent precipitating acute thiamine deficiency 1, 3
  • Carbamazepine (200 mg every 6-8 hours) can be used as an alternative to benzodiazepines for seizure prevention or as adjunctive therapy 1, 6
  • Haloperidol (0.5-5 mg every 8-12 hours) may be used carefully for agitation or psychotic symptoms not controlled by benzodiazepines 1, 3
  • Other adjunctive medications may include α2-agonists (clonidine and dexmedetomidine) and β-blockers to control autonomic hyperactivity 7

Treatment Setting and Monitoring

  • Inpatient treatment is recommended for cases with:
    • Serious complications
    • High levels of recent drinking
    • History of withdrawal seizures or delirium tremens
    • Co-occurring serious medical or psychiatric illness
    • Failure of outpatient treatment 1, 3
  • The Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised (CIWA-Ar) can guide treatment intensity:
    • Scores >8 indicate moderate AWS
    • Scores ≥15 indicate severe AWS requiring more aggressive treatment 3, 8
  • Patients with mild to moderate withdrawal symptoms without additional risk factors can be treated as outpatients 8
  • Outpatients should be monitored daily for up to five days after their last drink 8

Treatment Duration and Discontinuation

  • Treatment with benzodiazepines should be tapered following resolution of withdrawal symptoms 1, 3
  • Treatment duration should not exceed 10-14 days to avoid the risk of benzodiazepine dependence 1, 3
  • To reduce withdrawal reactions, use a gradual taper to discontinue diazepam or reduce the dosage 4

Common Pitfalls and Caveats

  • The CIWA protocol should not be used alone for diagnosis of AWS as high scores may be seen in other conditions 1, 3
  • Disulfiram and naltrexone should be avoided in patients with severe alcoholic liver disease due to potential hepatotoxicity 2, 3
  • Psychiatric consultation is recommended for evaluation, acute management of AWS, and long-term abstinence planning 1
  • Treatment of alcohol withdrawal should be followed by treatment for alcohol dependence to prevent recurrence 6, 8

References

Guideline

Medications for Treating Alcohol Withdrawal Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Treatment for Alcohol Withdrawal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Treatment for Alcohol Withdrawal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Alcohol withdrawal syndrome.

American family physician, 2004

Research

Alcohol Withdrawal Syndrome: Outpatient Management.

American family physician, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.